Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

nork Neu, H C, Meropol, N J, Fu, K P
Argitaratua 1981

Patient–physician discordance in goals of care for patients with advanced cancer

nork Douglas, S.L., Daly, B.J., Meropol, N.J., Lipson, A.R.
Argitaratua izan da Curr Oncol (2019)

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.

nork Mandelblatt, J S, Bierman, A S, Gold, K, Zhang, Y, Ng, J H, Maserejan, N, Hwang, Y T, Meropol, N J, Hadley, J, Silliman, R A
Argitaratua 2001

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

nork Dotan, E, Meropol, N J, Zhu, F, Zambito, F, Bove, B, Cai, K Q, Godwin, A K, Golemis, E A, Astsaturov, I, Cohen, S J
Argitaratua 2012

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

nork Cohen, S J, Konski, A A, Putnam, S, Ball, D S, Meyer, J E, Yu, J Q, Astsaturov, I, Marlow, C, Dickens, A, Cade, D N, Meropol, N J
Argitaratua 2014

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

nork Zurita, A J, Khajavi, M, Wu, H-K, Tye, L, Huang, X, Kulke, M H, Lenz, H-J, Meropol, N J, Carley, W, DePrimo, S E, Lin, E, Wang, X, Harmon, C S, Heymach, J V
Argitaratua izan da Br J Cancer (2015)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

nork MANNE, S., KASHY, D., ALBRECHT, T., WONG, Y.-N., FLAMM, A. LEDERMAN, BENSON, A. B., MILLER, S.M., FLEISHER, LINDA, BUZAGLO, J., ROACH, N., KATZ, M., ROSS, E., COLLINS, M., POOLE, D., RAIVITCH, S., MILLER, D.M., KINZY, T.G., LIU, T., MEROPOL, N.J.
Argitaratua izan da Eur J Cancer Care (Engl) (2014)